Human SNP ID | rs16865258 |
---|---|
Human chromosome | chr3 |
Human SNP position | 190279607 |
Pig chromosome | chr13 |
Pig SNP position | 136948148 |
PubMed ID | 21107309 |
---|---|
Journal | Neuropsychopharmacology |
Link | www.ncbi.nlm.nih.gov/pubmed/21107309 |
Study | Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia. |
Disease/Trait | Response to antipsychotic treatment in schizophrenia (working memory) |
Initial sample | 738 European ancestry, African American, and other ancestry cases |
Replication sample | NA |
Region | 3q28 |
Chromosome id | chr3 |
Chromosome position | 190279607 |
Reported gene | CLDN1 |
Mapped gene | P3H2-AS1 - CLDN1 |
Upstream gene id | 101929152 |
Downstream gene id | 9076 |
SNP gene ids | |
Upstream gene distance | 134761 |
Downstream gene distance | 26094 |
SNP risk allele | rs16865258-? |
SNPs | rs16865258 |
Merged | 0 |
SNP id current | 16865258 |
Context | intergenic_variant |
Intergenic | 1 |
Allele frequency | 0.02 |
P value | 0.000002 |
Pvalue mlog | 5.69897000433601 |
P value text | (quetiapine) |
Or beta | |
%95 Ci | |
Platform | Affymetrix [492900] |
CNV | N |
Mapped trait | short-term memory |
Mapped trait URI | http://www.ebi.ac.uk/efo/EFO_0004335 |
Study accession | GCST000883 |